---
title: "CHINARES PHARMA subsidiary TASLY earned 1.105 billion RMB for the year, an increase of 15.6%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279809963.md"
description: "China Resources Pharma announced that its subsidiary TASLY achieved an operating revenue of 8.236 billion RMB for the fiscal year 2025, a year-on-year decrease of 3.1%. The net profit attributable to shareholders was 1.105 billion RMB, an increase of 15.6%, with earnings per share of 0.74 RMB"
datetime: "2026-03-19T14:32:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279809963.md)
  - [en](https://longbridge.com/en/news/279809963.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279809963.md)
---

# CHINARES PHARMA subsidiary TASLY earned 1.105 billion RMB for the year, an increase of 15.6%

China Resources Pharmaceutical (03320.HK) announced that its subsidiary TASLY (600535.SH) achieved an operating revenue of 8.236 billion (RMB) for the fiscal year 2025, a year-on-year decrease of 3.1%. The net profit attributable to shareholders was 1.105 billion, an increase of 15.6%, with earnings per share of 0.74

### Related Stocks

- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [03320.HK](https://longbridge.com/en/quote/03320.HK.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [600535.CN](https://longbridge.com/en/quote/600535.CN.md)

## Related News & Research

- [Tasly Delivers Profit Growth on Flat Revenue, Bolstering China Resources Pharmaceutical](https://longbridge.com/en/news/292626345.md)
- [China Resources Pharmaceutical Moves to Become Largest Shareholder in Lier Chemical](https://longbridge.com/en/news/294273054.md)